rs144386291

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001127208.3(TET2):​c.2599T>C​(p.Tyr867His) variant causes a missense change. The variant allele was found at a frequency of 0.0105 in 1,614,090 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y867C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0066 ( 5 hom., cov: 32)
Exomes 𝑓: 0.011 ( 114 hom. )

Consequence

TET2
NM_001127208.3 missense

Scores

9
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 6.83

Publications

46 publications found
Variant links:
Genes affected
TET2 (HGNC:25941): (tet methylcytosine dioxygenase 2) The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
TET2-AS1 (HGNC:41125): (TET2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005108267).
BP6
Variant 4-105236541-T-C is Benign according to our data. Variant chr4-105236541-T-C is described in ClinVar as Benign. ClinVar VariationId is 135323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00664 (1012/152296) while in subpopulation NFE AF = 0.011 (749/68018). AF 95% confidence interval is 0.0104. There are 5 homozygotes in GnomAd4. There are 444 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127208.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TET2
NM_001127208.3
MANE Select
c.2599T>Cp.Tyr867His
missense
Exon 3 of 11NP_001120680.1
TET2
NM_017628.4
c.2599T>Cp.Tyr867His
missense
Exon 3 of 3NP_060098.3
TET2-AS1
NR_126420.1
n.319-58869A>G
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TET2
ENST00000380013.9
TSL:5 MANE Select
c.2599T>Cp.Tyr867His
missense
Exon 3 of 11ENSP00000369351.4
TET2
ENST00000513237.5
TSL:1
c.2662T>Cp.Tyr888His
missense
Exon 3 of 11ENSP00000425443.1
TET2
ENST00000540549.5
TSL:1
c.2599T>Cp.Tyr867His
missense
Exon 3 of 11ENSP00000442788.1

Frequencies

GnomAD3 genomes
AF:
0.00664
AC:
1011
AN:
152178
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00232
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00628
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0110
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00734
AC:
1840
AN:
250772
AF XY:
0.00739
show subpopulations
Gnomad AFR exome
AF:
0.00191
Gnomad AMR exome
AF:
0.00631
Gnomad ASJ exome
AF:
0.00755
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00194
Gnomad NFE exome
AF:
0.0120
Gnomad OTH exome
AF:
0.00932
GnomAD4 exome
AF:
0.0110
AC:
16012
AN:
1461794
Hom.:
114
Cov.:
34
AF XY:
0.0106
AC XY:
7692
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.00197
AC:
66
AN:
33480
American (AMR)
AF:
0.00658
AC:
294
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00696
AC:
182
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39658
South Asian (SAS)
AF:
0.00225
AC:
194
AN:
86258
European-Finnish (FIN)
AF:
0.00202
AC:
108
AN:
53412
Middle Eastern (MID)
AF:
0.00832
AC:
48
AN:
5768
European-Non Finnish (NFE)
AF:
0.0131
AC:
14575
AN:
1111986
Other (OTH)
AF:
0.00902
AC:
545
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1006
2012
3019
4025
5031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00664
AC:
1012
AN:
152296
Hom.:
5
Cov.:
32
AF XY:
0.00596
AC XY:
444
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00231
AC:
96
AN:
41572
American (AMR)
AF:
0.00628
AC:
96
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4826
European-Finnish (FIN)
AF:
0.00160
AC:
17
AN:
10610
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0110
AC:
749
AN:
68018
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
58
116
175
233
291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0101
Hom.:
38
Bravo
AF:
0.00710
TwinsUK
AF:
0.0129
AC:
48
ALSPAC
AF:
0.0145
AC:
56
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.0124
AC:
107
ExAC
AF:
0.00689
AC:
837
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0125
EpiControl
AF:
0.0137

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TET2: BS1, BS2

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1Other:1
Apr 28, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.53
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.33
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.079
T
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.89
D
MetaRNN
Benign
0.0051
T
MetaSVM
Benign
-1.2
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
6.8
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.21
Sift
Uncertain
0.0020
D
Sift4G
Benign
0.50
T
Polyphen
1.0
D
Vest4
0.63
MVP
0.46
MPC
0.46
ClinPred
0.017
T
GERP RS
5.8
Varity_R
0.22
gMVP
0.51
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144386291; hg19: chr4-106157698; COSMIC: COSV54409754; COSMIC: COSV54409754; API